Expression of HSD17B6 in prostate cancer samples with bone metastasis were significantly lower than that in non-metastatic counterparts [10], indicating the dysfunction of HSD17B6 in cancer metastases. This evidence concerns the gene HSD17B6 and prostate carcinoma.